Assessing side effects of pharmacotherapy treatment of bipolar disorder: A 20-year review of the literature

Research in Developmental Disabilities

Volumn 27, Issue 5, 2006, Pages 467-500

  Matson, Johnny L ^a   González, Melissa L ^a   Smith, Kimberly R ^a   Terlonge, Cindy ^a   Thorson, Ryan T ^a   Dixon, Dennis R ^a  

^a LOUISIANA STATE UNIVERSITY   (United States)

Author keywords

Bipolar disorder; Pharmacotherapy

Indexed keywords

ALKALINE PHOSPHATASE; AMFEBUTAMONE; ANTIDEPRESSANT AGENT; ATYPICAL ANTIPSYCHOTIC AGENT; CARBAMAZEPINE; CLONAZEPAM; CLONIDINE; CLOZAPINE; FLUOXETINE; GABAPENTIN; GAMMA GLUTAMYLTRANSFERASE; HALOPERIDOL; IDAZOXAN; INOSITOL; LAMOTRIGINE; LEVOTHYROXINE SODIUM; LITHIUM; LITHIUM CARBONATE; LORAZEPAM; MOOD STABILIZER; OLANZAPINE; OXCARBAZEPINE; PRAMIPEXOLE; QUETIAPINE; RISPERIDONE; UNINDEXED DRUG; VALPROATE SEMISODIUM; VALPROIC ACID; VENLAFAXINE; VERAPAMIL;

ACNE CYSTICA; AGITATION; AGRANULOCYTOSIS; AKATHISIA; ALOPECIA; AMNESIA; ANOREXIA; ANORGASMIA; ANTICHOLINERGIC SYNDROME; ANXIETY; APATHY; ARTICLE; ASTHENIA; ATTENTION DISTURBANCE; BACKACHE; BASAL CELL CARCINOMA; BIPOLAR DISORDER; BLURRED VISION; BRADYCARDIA; CATATONIA; CHEST TIGHTNESS; COGNITIVE DEFECT; CONFUSION; CONSTIPATION; CONVULSION; COST BENEFIT ANALYSIS; DECREASED APPETITE; DEHYDRATION; DELIRIUM; DEPRESSION; DEPRESSIVE PSYCHOSIS; DIABETIC KETOACIDOSIS; DIARRHEA; DIPLOPIA; DISEASE EXACERBATION; DIZZINESS; DROWSINESS; DRUG EFFICACY; DRUG MEGADOSE; DRY EYE; DYSARTHRIA; DYSPEPSIA; DYSPHORIA; DYSPNEA; DYSTONIA; EDEMA; EMOTIONAL INCONTINENCE; EMOTIONAL STRESS; EXTRAPYRAMIDAL SYMPTOM; FAINTNESS; FATIGUE; FEVER; FLATULENCE; GAIT DISORDER; GASTROINTESTINAL SYMPTOM; GRAND MAL SEIZURE; HAIR LOSS; HALLUCINATION; HAND TREMOR; HEADACHE; HEART PALPITATION; HOSTILITY; HUMAN; HYPERKINESIA; HYPERSALIVATION; HYPERTENSION; HYPERTHYROIDISM; HYPOMANIA; HYPONATREMIA; HYPOTENSION; HYPOTHYROIDISM; INCREASED APPETITE; INFECTION; INFLUENZA; INJURY; INSOMNIA; INTELLECTUAL IMPAIRMENT; IRRITABILITY; LASSITUDE; LEUKOPENIA; LIVER DISEASE; LIVER DYSFUNCTION; LONG TERM CARE; LOOSE FECES; LYMPHADENOPATHY; MALAISE; MEMORY DISORDER; MENSTRUATION DISORDER; MUSCLE HYPERTONIA; MUSCLE WEAKNESS; MYALGIA; NAUSEA; NAUSEA AND VOMITING; NERVOUSNESS; NIGHTMARE; NYSTAGMUS; PAIN; PANIC; PARESTHESIA; PARKINSONISM; PATIENT MONITORING; PERSONALITY DISORDER; PHARYNGITIS; POLYDIPSIA; POLYURIA; PRURITUS; PSORIASIS; RASH; RECTUM DISEASE; RESTLESSNESS; RHINITIS; SEDATION; SEXUAL DYSFUNCTION; SIDE EFFECT; SINUS CONGESTION; SLEEP DISORDER; SLURRED SPEECH; SOMNOLENCE; STOMACH HEMORRHAGE; SUICIDAL BEHAVIOR; SWEATING; SYNCOPE; TACHYCARDIA; TARDIVE DYSKINESIA; THIRST; THORAX PAIN; THROMBOCYTOPENIA; TINNITUS; TONGUE EDEMA; TOXIC HEPATITIS; TREMOR; UNSPECIFIED SIDE EFFECT; URINE INCONTINENCE; URTICARIA; VOMITING; WEIGHT GAIN; WEIGHT REDUCTION; XEROSTOMIA;

ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; HUMANS; TIME FACTORS;

EID: 33748548739     PISSN: 08914222     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ridd.2005.06.002     Document Type: Article

References (23)

1. American Psychiatric Association. Practice guidelines for the treatment of patients with bipolar disorder. American Journal of Psychiatry 159 (2002) 1-50 (Rev.)
2. Antonacci D.J., and de Groot C.M. Clozapine treatment in a population of adults with mental retardation. The Journal of Clinical Psychiatry 61 (2000) 22-25
3. Buzan R.D., Dubovsky S.L., Firestone D., and Dal Pozzo E. Use of clozapine in 10 mentally retarded adults. The Journal of Neuropsychiatry and Clinical Neurosciences 10 (1998) 93-95
4. Carta M.G., Hardoy M.C., Dessi I., Hardoy M.J., and Carpiniello B. Adjunctive gabapentin in patients with intellectual disability and bipolar spectrum disorders. Journal of Intellectual Disability Research 45 (2001) 139-145
5. Frank E., and Swartz H.A. Interpersonal and social rhythm therapy. In: Johnson S.L., and Leahy R.L. (Eds). Psychological treatment of bipolar disorder (2004), Guild Press, New York 162-183
6. Fukuda K., Etoh T., and Okuma T. Affective disorders in mentally retarded adolescents-Report of two cases with lithium treatment. The Japanese Journal of Psychiatry and Neurology 40 (1986) 551-557
7. Geddes J., Freemantle N., Harrison P., and Bebbington P. Atypical antipsychotics in the treatment of schizophrenia: Systematic overview and meta-regression analysis. British Medical Journal 321 (2000) 1371-1376
8. Geddes J., and Goodwin G. Bipolar disorder: Clinical uncertainty, evidence-based medicine and large-scale randomized trials. British Journal of Psychiatry 178 (2001) S191-S194
9. Goldberg J.F. The changing landscape of psychopharmacology. In: Johnson S.L., and Leahy R.L. (Eds). Psychological treatment of bipolar disorder (2004), Guild Press, New York 3-16
10. Hirschfeld, R. M. A., Bowden, C. L., Gitlin, M. J., Keck, P. E., Suppes, T., Thase, M. E., et al. (2002). Practice guidelines for the treatment of patients with bipolar disorder. American Psychiatric Association practice guidelines for the treatment of psychiatric disorders: Compendium 2002 (2nd ed., pp. 547-634). Washington, DC: American Psychiatric Association.
11. Hoyer E.H., Olesen A.V., and Mortensen P.B. Suicide risk in patients hospitalized because of an affective disorder: A follow-up study, 1973-1993. Journal of Affective Disorders 78 (2004) 209-217
12. Jeste D.V., and Caliguri M.P. Tardive dyskinesia. Schizophrenia Bulletin 19 (1993) 303-314
13. Johnson S.L. Defining bipolar disorder. In: Johnson S.L., and Leahy R.L. (Eds). Psychological treatment of bipolar disorder (2004), Guild Press, New York 3-16
14. Kasper S., and Attarbaschi T. Treatment options for bipolar mania. Clinical Approaches in Bipolar Disorders 3 (2004) 24-32
15. Matson, J. L., Dixon, D. R., González, M. L., & Matson, M. L. (2005). Pharmacological treatment of bipolar adults: A review and analysis, submitted for publication.
16. Meyer J.M., and Koro C.E. The effects of antipsychotic therapy on serum lipids: A comprehensive review. Schizophrenia Research 70 (2004) 1-17
17. Montgomery S.A., Schatzberg A.F., Guelfi J.D., Kasper S., Nemeroff C., and Zajecka J. Pharmacotherapy of depression and mixed states in bipolar disorder. Journal of Affective Disorders 59 (2002) S39-S56
18. Pary R. Side effects during lithium treatment for psychiatric disorder in adults with mental retardation. American Journal of Mental Retardation 96 (1991) 269-273
19. Pary R. Clozapine in three individuals with mild mental retardation and treatment-refractory psychiatric disorders. Mental Retardation 32 (1994) 323-327
20. Sovner R. The use of valproate in the treatment of mentally retarded persons with typical and atypical bipolar disorders. Journal of Clinical Psychiatry 50 (1989) 40-43
21. Thalayasingam S., Alexander R.T., and Singh I. The use of clozapine in adults with intellectual disability. Journal of Intellectual Disability Research 48 (2004) 572-579
22. Tohen M., Zhang F., Taylor C.C., Burns P., Zarate C., Sanger T., et al. A meta-analysis of the use of typical antipsychotic agents in bipolar disorder. Journal of Affective Disorders 65 (2001) 85-93
23. Wilson J.G., Lott R.S., and Tsai L. Side effects: Recognition and management. In: Reiss S., and Aman M.G. (Eds). Psychotropic medications and developmental disabilities. The international consensus handbook (1998), The Ohio State University Nisonger Center, Columbus, OH 95-114